
Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial
Publication
, Conference
Colon-Emeric, CS; Eriksen, EF; Lyles, KW; Pieper, CF; Magaziner, JS; Adachi, JD; Hyldstrup, L; Recknor, C; Nordsletten, L; Lavecchia, C; Hu, H ...
Published in: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
April 1, 2008
Duke Scholars
Published In
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
ISSN
0002-8614
Publication Date
April 1, 2008
Volume
56
Issue
4
Start / End Page
S17 / S17
Location
Washington, DC
Publisher
BLACKWELL PUBLISHING
Conference Name
Annual Meeting of the American-Geriatrics-Society
Related Subject Headings
- Geriatrics
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Colon-Emeric, C. S., Eriksen, E. F., Lyles, K. W., Pieper, C. F., Magaziner, J. S., Adachi, J. D., … Mesenbrink, P. (2008). Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (Vol. 56, pp. S17–S17). Washington, DC: BLACKWELL PUBLISHING.
Colon-Emeric, C. S., E. F. Eriksen, K. W. Lyles, C. F. Pieper, J. S. Magaziner, J. D. Adachi, L. Hyldstrup, et al. “Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial.” In JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 56:S17–S17. BLACKWELL PUBLISHING, 2008.
Colon-Emeric CS, Eriksen EF, Lyles KW, Pieper CF, Magaziner JS, Adachi JD, et al. Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. In: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. BLACKWELL PUBLISHING; 2008. p. S17–S17.
Colon-Emeric, C. S., et al. “Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial.” JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, vol. 56, no. 4, BLACKWELL PUBLISHING, 2008, pp. S17–S17.
Colon-Emeric CS, Eriksen EF, Lyles KW, Pieper CF, Magaziner JS, Adachi JD, Hyldstrup L, Recknor C, Nordsletten L, Lavecchia C, Hu H, Boonen S, Mesenbrink P. Timing of dosing of zoledronic acid 5mg after recent hip fracture affects antifracture efficacy and reduction of mortality: HORIZON-Recurrent fracture trial. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. BLACKWELL PUBLISHING; 2008. p. S17–S17.

Published In
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
ISSN
0002-8614
Publication Date
April 1, 2008
Volume
56
Issue
4
Start / End Page
S17 / S17
Location
Washington, DC
Publisher
BLACKWELL PUBLISHING
Conference Name
Annual Meeting of the American-Geriatrics-Society
Related Subject Headings
- Geriatrics
- 52 Psychology
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences